Xiong 'an Center of Beijing-Tianjin-Hebei National Technology Innovation Center officially started operation. On December 12th, Xiong 'an Center of Beijing-Tianjin-Hebei National Technology Innovation Center officially started operation, including the cooperation project of Xiong 'an Medical and Industrial Cross Transformation Research Institute of Peking University People's Hospital and the fourth generation semiconductor material doped AlN epitaxial wafer, and many independent innovative projects landed in xiong'an new area. As a national innovation platform, Xiong 'an Center will focus on key tasks such as building a first-class innovation platform, forming a composite innovation team, and improving the innovation and entrepreneurship ecology, and strive to create an important source of independent innovation and original innovation. (CCTV News)Runhe Software and other 300 million yuan set up a venture capital fund partnership. The enterprise search APP shows that Yuanshi (Changzhou) venture capital fund partnership (limited partnership) was established recently with a capital contribution of 300 million yuan, and its business scope includes: venture capital (limited investment in unlisted enterprises); Engage in equity investment, investment management, asset management and other activities with private equity funds. Enterprise equity penetration shows that the enterprise is jointly held by Runhe Software.The project of Chuangpu Instrument Industrial Park started in Hefei, with a total investment of 320 million yuan. According to the news of Hefei High-tech Zone Management Committee, on December 10th, the project of Chuangpu Instrument Industrial Park at the intersection of Caihong West Road and Peacock Terrace Road in Hefei High-tech Zone officially started. The total investment of the project is 320 million yuan, which is planned to be completed at one time and is expected to be put into use in the second half of 2027.
OPEC continues to lower its global oil demand forecast. According to Xinhua News Agency, the Organization of Petroleum Exporting Countries (OPEC) released its monthly oil market report on the 11th, lowering its global oil demand forecast for 2024 and 2025. This is the fifth time that OPEC has lowered its global oil demand forecast for this year and next since August this year.The Chinese medicine sector collectively pulled up Panlong Pharmaceutical's linear daily limit, Panlong Pharmaceutical's linear daily limit, Xiangxue Pharmaceutical, Kunyao Group, Huasen Pharmaceutical, Jingxin Pharmaceutical, Xinguang Pharmaceutical and Changyao Holdings followed suit.Beijing Haidian Joy City will open on December 21st. According to WeChat official account news of "Beijing Haidian" WeChat, Haidian Joy City, the fourth joy city in Beijing, will open on December 21st. At present, many brands have come to an end, and the merchants in the venue have entered the preparations for opening. It is understood that Haidian Joy City is expected to introduce more than 280 brands.
The turnover of Shanghai, Shenzhen and Beijing exceeded 1 trillion yuan, 15.6 billion yuan more than the previous day. Up to now, the turnover of Shanghai, Shenzhen and Beijing exceeded 1 trillion yuan, 15.6 billion yuan more than the previous day. Among them, the turnover of Shanghai Stock Exchange was 378.3 billion yuan, that of Shenzhen Stock Exchange was 611.9 billion yuan, and that of Beizheng 50 was 10.5 billion yuan.The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.The annual passenger flow at the West Kowloon Station Port exceeded 25 million for the first time. It was learned from the West Kowloon Border Inspection Station of Shenzhen Border Inspection Station that as of 24: 00 on December 11th, the cumulative passenger flow at the West Kowloon Border Inspection Station exceeded 25 million for the first time this year, accounting for 36.7% of the total passenger flow since the opening of the West Kowloon Station Port, an increase of 36.5% compared with last year, an increase of 33% on average daily passenger flow, and 32.5% of foreign passengers entering the country without visas. Inspection ensures that cross-border trains increase by 36% year-on-year, and "customs clearance flow" helps "economic growth", injecting border inspection momentum into the country's high-level open and high-quality development. (Voice of Greater Bay Area)
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide